Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
TELK [NASD]
Telik Inc.
Index- P/E- EPS (ttm)-1.18 Insider Own0.28% Shs Outstand4.58M Perf Week-2.88%
Market Cap6.18M Forward P/E- EPS next Y- Insider Trans-92.07% Shs Float4.55M Perf Month-7.53%
Income-5.20M PEG- EPS next Q- Inst Own4.90% Short Float0.45% Perf Quarter-19.64%
Sales- P/S- EPS this Y67.90% Inst Trans0.90% Short Ratio0.38 Perf Half Y5.47%
Book/sh0.37 P/B3.65 EPS next Y- ROA-120.20% Target Price1.05 Perf Year8.00%
Cash/sh0.48 P/C2.81 EPS next 5Y- ROE-167.70% 52W Range1.05 - 2.15 Perf YTD13.45%
Dividend- P/FCF- EPS past 5Y42.10% ROI- 52W High-37.21% Beta0.05
Dividend %- Quick Ratio2.60 Sales past 5Y- Gross Margin- 52W Low28.57% ATR0.10
Employees11 Current Ratio2.60 Sales Q/Q- Oper. Margin- RSI (14)43.88 Volatility4.20% 6.37%
OptionableNo Debt/Eq0.00 EPS Q/Q74.20% Profit Margin- Rel Volume0.04 Prev Close1.34
ShortableYes LT Debt/Eq0.00 EarningsAug 05 Payout- Avg Volume54.53K Price1.35
Recom3.00 SMA20-6.05% SMA50-3.76% SMA2001.69% Volume2,271 Change0.75%
09-Oct-07Reiterated Lehman Brothers Underweight $3 → $1.75
28-Sep-07Initiated BMO Capital Markets Market Perform $3
05-Jun-07Downgrade Wachovia Outperform → Mkt Perform
17-Apr-07Upgrade Stifel Nicolaus Sell → Hold
17-Apr-07Upgrade Janney Mntgmy Scott Sell → Neutral
03-Jan-07Downgrade Bear Stearns Outperform → Peer Perform
14-Mar-14 01:04PM  TELIK INC Financials EDGAR Online Financials
01:04PM  TELIK INC Financials
10-Mar-14 04:44PM  TELIK INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:15PM  Telik Announces Fourth Quarter And 2013 Year End Financial Results PR Newswire
03-Mar-14 04:05PM  TELIK INC Files SEC form 8-K, Other Events EDGAR Online
15-Jan-14 04:46PM  TELIK INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfe EDGAR Online
04:46PM  TELIK INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfe
20-Nov-13 04:31PM  TELIK INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfe EDGAR Online
04:31PM  TELIK INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfe
12-Nov-13 04:50PM  TELIK INC Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits EDGAR Online +20.16%
04:50PM  TELIK INC Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
04:47PM  TELIK INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:47PM  TELIK INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:20PM  Telik Announces Third Quarter 2013 Financial Results PR Newswire
04:20PM  Telik Announces Third Quarter 2013 Financial Results
23-Aug-13 04:03PM  TELIK INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits EDGAR Online
04:03PM  TELIK INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
20-Aug-13 01:04PM  TELIK INC Financials EDGAR Online Financials
01:04PM  TELIK INC Financials
09-Aug-13 04:31PM  TELIK INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:31PM  TELIK INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:15PM  Telik Announces Second Quarter 2013 Financial Results PR Newswire
04:15PM  Telik Announces Second Quarter 2013 Financial Results
21-May-13 01:04PM  TELIK INC Financials EDGAR Online Financials
20-May-13 10:22AM  TELIK INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Security EDGAR Online
10:22AM  TELIK INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Security
10-May-13 04:30PM  Telik Announces First Quarter 2013 Financial Results PR Newswire
09:55AM  TELIK INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
05-Apr-13 01:32AM  Telik: A Possible Investment, But Only After Much Consideration at Seeking Alpha
21-Mar-13 01:04PM  TELIK INC Financials EDGAR Online Financials
15-Mar-13 04:46PM  TELIK INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:30PM  Telik Announces Fourth Quarter And 2012 Year End Financial Results And 2013 Financial Guidance PR Newswire
05-Mar-13 05:08PM  TELIK INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
22-Feb-13 05:11PM  TELIK INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
24-Jan-13 06:18AM  Is There Value In Telik? at Seeking Alpha
23-Jan-13 04:00PM  4 Healthcare Stock Stories for Wednesday Wellness at Wall St. Cheat Sheet
06:03AM  TELIK INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
22-Jan-13 05:31PM  InPlay: Telik announces preliminary agreement on design of Phase 3 registration trial of Telintra in low to intermediate-1 risk myelodysplastic syndrome Briefing.com
05:30PM  Telik Announces Preliminary Agreement On Design Of Phase 3 Registration Trial Of Telintra® In Low To Intermediate-1 Risk Myelodysplastic Syndrome PR Newswire
16-Jan-13 11:37AM  The Long And Short Cases For Telik at Seeking Alpha -12.06%
14-Jan-13 02:35PM  Between A Rock And A Hard Place: Telik Needs Cash at Seeking Alpha -24.50%
13-Jan-13 02:01AM  Is It Time To Go Long Or Short Telik? at Seeking Alpha
11-Jan-13 07:23PM  Telik Announces Orphan Designation Of Telintra® For Treatment Of Myelodysplastic Syndrome PR Newswire +105.52%
05:45PM  4 Healthcare Stock Stories for Investor Wellbeing at Wall St. Cheat Sheet
12-Dec-12 04:30PM  Telik publishes clinical trial abstract on ICN treatment at theflyonthewall.com +7.32%
04:20PM  Telik Announces Telintra® Clinical Publication at the 54th Annual Meeting of the American Society of Hematology PR Newswire
04:16PM  Is Telik A Good Buy After Increasing 24% In One Day? at Seeking Alpha
22-Nov-12 01:05PM  TELIK INC Financials EDGAR Online Financials
09-Nov-12 04:28PM  TELIK INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online +6.98%
04:15PM  Telik Announces Third Quarter 2012 Financial Results PR Newswire
28-Aug-12 09:29AM  5 Stocks Trading Below Net Cash - Part VI at Seeking Alpha
18-Aug-12 01:04PM  TELIK INC Financials EDGAR Online Financials
10-Aug-12 04:20PM  TELIK INC Files SEC form 10-Q, Quarterly Report EDGAR Online
04:19PM  TELIK INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  Telik Announces Second Quarter 2012 Financial Results PR Newswire
10-Jul-12 11:31AM  Vringo, Telik Gapping Up Tuesday at Fox Business
10:56AM  Vringo, Telik Gapping Up Tuesday at Fox Business
05-Jul-12 05:32PM  Gevo, VelocityShares 3x Inverse Natural Gas ETN linked to the S&P GSCI Natural Gas Index Excess Return Among Stocks setting 52-Week Lows Thursday at Fox Business -11.33%
04:58PM  Gevo, VelocityShares 3x Inverse Natural Gas ETN linked to the S&P GSCI Natural Gas Index Excess Return Among Stocks setting 52-Week Lows Thursday at Fox Business
04:56PM  Gevo, VelocityShares 3x Inverse Natural Gas ETN linked to the S&P GSCI Natural Gas Index Excess Return Among Stocks setting 52-Week Lows Thursday at Fox Business
27-Jun-12 05:47PM  Health Care Sector Wrap at Fox Business -11.86%
05:12PM  Health Care Sector Wrap at Fox Business
25-May-12 06:09PM  Nasdaq stocks posting largest percentage increases AP -6.94%
01:29PM  Nasdaq stocks posting largest percentage increases AP
24-May-12 06:06PM  Nasdaq stocks posting largest percentage increases AP +29.79%
01:38PM  Nasdaq stocks posting largest percentage increases AP
22-May-12 01:05PM  TELIK INC Financials EDGAR Online Financials -7.29%
15-May-12 06:15AM  Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Respons PR Newswire -8.70%
14-May-12 04:56PM  Health Care Sector Wrap at Fox Business +15.00%
09-May-12 04:31PM  TELIK INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:15PM  Telik Announces First Quarter 2012 Financial Results PR Newswire
02-May-12 06:07AM  TELIK INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
17-Apr-12 05:18PM  TELIK INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
05:01PM  InPlay: Telik regains compliance with minimum bid price requirement Briefing.com
04:59PM  Telik Regains Compliance With Minimum Bid Price Requirement PR Newswire
16-Apr-12 04:56PM  Health Care Sector Wrap at Fox Business +11.50%
02-Apr-12 11:42AM  Telik dives 19% on reverse-stock split at MarketWatch
30-Mar-12 02:00PM  TELIK INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters EDGAR Online
01:00PM  InPlay: Telik announces 1-for-30 reverse split of common stock Briefing.com
01:00PM  Telik Announces Reverse Split of Common Stock PR Newswire
03-Mar-12 01:04PM  TELIK INC Financials EDGAR Online Financials
27-Feb-12 05:17PM  TELIK INC Files SEC form 10-K, Annual Report EDGAR Online
23-Feb-12 04:42PM  TELIK INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:27PM  InPlay: Telik reported a net loss of ($0.05) vs ($0.07) single CIQ estimate Briefing.com
04:05PM  Telik Announces Fourth Quarter and 2011 Year End Financial Results and 2012 Financial Guidance PR Newswire
07:07AM  Q4 2011 Telik Inc Earnings Release - Time Not Supplied CCBN
21-Feb-12 09:05AM  Telik Announces Expansion of Phase 2 Trial of Telcyta in Hematologic Malignancies PR Newswire
08-Feb-12 09:05AM  Telik Announces Presentation and Webcast at 14th Annual BIO CEO & Investor Conference PR Newswire
25-Jan-12 06:11PM  Nasdaq stocks posting largest volume increases AP
04-Jan-12 09:00AM  Telik Announces Presentation and Webcast at 5th Annual OneMedForum Conference PR Newswire
22-Dec-11 06:16PM  Nasdaq stocks posting largest volume increases AP
14-Dec-11 06:13PM  Nasdaq stocks posting largest volume increases AP
13-Dec-11 09:12AM  Telik announces data from Phase 1 study of telintra in combination with revlimid theflyonthewall.com
09:01AM  InPlay: Telik announces the results of genetic signature studies of myelodysplastic syndrome patients likely to respond to Telintra Briefing.com
09:00AM  Telik Announces the Results of Genetic Signature Studies of Myelodysplastic Syndrome Patients Likely to Respond to Telintra® (Ezatiostat Hydrochloride, TLK199) at the Annual Meeting of the American Society of Hematology PR Newswire
09:00AM  Telik Announces Phase 1 Results of a Multicenter Study of Telintra® (Ezatiostat Hydrochloride, TLK199) in Combination with Revlimid® (Lenalidomide) in Patients with Myelodysplastic Syndrome PR Newswire
Telik, Inc., a clinical-stage drug development company, focuses on discovering and developing small molecule drugs to treat cancer. The company's product candidates are discovered using its proprietary technology, target-related affinity profiling (TRAP), which enables the discovery of small molecule product candidates. Its lead drug product candidate in clinical development includes TELINTRA, a small molecule glutathione analog inhibitor of the enzyme glutathione S-transferase P1-1, which is under Phase II clinical trial for the treatment of blood disorders associated with low blood cell levels, such as anemia, neutropenia, or thrombocytopenia. The company's preclinical drug product developments include TLK60404, a small molecule compound, which inhibits Aurora kinase and VEGFR kinase; TLK60357, a small molecule inhibitor of cell division that inhibits the formation of microtubules necessary for cancer cell growth leading to persistent cancer cell cycle block and subsequent cell death at the G2/M phase; and TLK60596, a VEGFR1 and VEGFR2 kinase inhibitor that blocks the formation of new blood vessels in tumors. Telik, Inc. was founded in 1988 and is based in Palo Alto, California.